ofloxacin has been researched along with ampicillin in 101 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (12.87) | 18.7374 |
1990's | 22 (21.78) | 18.2507 |
2000's | 39 (38.61) | 29.6817 |
2010's | 23 (22.77) | 24.3611 |
2020's | 4 (3.96) | 2.80 |
Authors | Studies |
---|---|
Aghatabay, NM; Dülger, B; Haciu, D; Karabiyik, T; Neshat, A; Somer, M | 1 |
Aghatabay, NM; Dulger, B; Gucin, F; Senel, M; Somer, M | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
Aghatabay, NM; Cevik, H; Dulger, B; Mahmiani, Y | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Hansen, S; Lewis, K; Vulić, M | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Goy, G; Greub, G | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Aghatabay, NM; Baş, A; Dülger, B; Gücin, F; Kircali, A; Sen, G; Yazicioğlu, MB | 1 |
Hashida, Y; Konaka, R; Kourai, H; Maseda, H; Shirai, A | 1 |
Barbut, F; Bouttier, S; Collignon, A; Denève, C; Dupuy, B; Janoir, C | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Goswami, M; Jawali, N | 1 |
Aytemir, MD; Ozçelik, B | 1 |
Fargualy, AM; Habib, NS; Hassan, AM; Ismail, KA; Sarg, MT | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Álvarez, A; Arocha, I; Chávez, K; Compagnone, RS; Figarella, K; Galindo-Castro, I; Marsiccobetre, S; Orsini, G; Suárez, AI; Taddei, A; Tillett, S; Triviño, J | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Dwoskin, LP; Garneau-Tsodikova, S; Green, KD; Kril, LM; Kwiatkowski, S; Nickell, JR; Shrestha, SK; Sviripa, VM; Watt, DS | 1 |
Zhang, B | 1 |
Blanco, C; Demay, F; Dhalluin, A; Ermel, G; Georgeault, S; Giard, JC; Gillet, R; Gomes Von Borowski, R; Hanh Le, H; Jean, M; Radigue, R; Thepaut, M; Trautwetter, A; Tresse, C; van de Weghe, P | 1 |
De Simone, C; Delia, S; Famularo, G; Moretti, S; Trinchieri, V; Tzantzoglou, S | 1 |
Göker, K; Güvener, O | 1 |
Hayran, M; Kocagöz, T; Sener, B; Ustaçelebi, S | 1 |
Fu, KP; Hilliard, J; Isaacson, D; McGuire, JL; Rosenthale, ME; Tobia, AJ | 1 |
Higashide, Y; Sakano, T; Takahashi, I; Yoshida, T | 1 |
Faegri, A; Melby, K | 1 |
Akalin, HE; Baykal, M | 1 |
Satoh, T; Sugimoto, R | 1 |
Grohe, K; Metzger, KG; Schacht, P; Zeiler, HJ | 1 |
Ashihara, Y; Bannai, H; Miyazawa, H | 1 |
Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
Egede, F; Kristensen, I | 1 |
Yuzawa, N | 1 |
Debbia, E; Gianrossi, G; Mannelli, S; Schito, GC | 1 |
Caccamo, F; Nicoletti, G; Nicolosi, VM; Speciale, A; Stefani, S | 1 |
Carlstedt-Duke, B; Høverstad, T; Lingaas, E; Midtvedt, T; Norin, KE; Saxerholt, H; Steinbakk, M | 1 |
Borner, K; Kemmerich, B; Pennington, JE | 1 |
Klesel, N; Limbert, M; Schrinner, E; Seibert, G; Winkler, I | 1 |
Arman, D; Tural, D; Willke, A | 1 |
Cherubin, CE; Stratton, CW | 1 |
Hayden, MK; Matushek, MG; Trenholme, GM | 1 |
de Górgolas, M; Fernández Guerrero, ML; Fernández Roblas, R; Torres Perea, R; Verdejo Morcillo, C | 1 |
Herbert, D; Kubendiran, G; Mitchison, DA; Paramasivan, CN; Prabhakar, R; Venkatesan, P | 1 |
Okonogi, K; Tsuchimori, N; Yamazaki, T | 1 |
Baker, PD; Fernau, R; Landon, GC; Lipsky, BA | 1 |
Barrett, JF; Foleno, BE; Frosco, MB; Smith, CE | 1 |
Aikawa, N; Denno, R; Fujimoto, M; Hirata, AK; Ishibiki, K; Ishihara, R; Ishikawa, S; Iwai, S; Kinoshita, H; Koide, H; Kunimatsu, M; Manabe, T; Mashita, K; Mizuno, A; Morimoto, K; Mukaiya, M; Ohnishi, H; Ohtsuka, K; Sakaguchi, S; Shinagawa, N; Takuma, K; Tanimura, H; Umemoto, Y; Ushijima, Y; Yura, J | 1 |
Andriole, VT; Dembry, LM; Farrel, PA; Gerrity, LA; Orcutt, DR | 1 |
Kim, YB; Park, MS | 1 |
Igari, J; Nakamura, A; Oguri, T; Tabe, Y | 1 |
Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
Lacy, MK; Lu, W; Nicolau, DP; Nightingale, CH; Quintiliani, R; Tessier, PR; Xu, X | 1 |
Dabernat, H | 1 |
Chiba, A; Harada, S; Hasegawa, M; Kaneko, A; Kobayashi, I; Koyama, H; Matsuzaki, K; Omika, K; Sasaki, J; Sato, Y | 1 |
Guseĭnov, KhIu | 1 |
Guttigoli, A; Zaman, MM | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 1 |
Hostacká, A | 1 |
Chuma, T; Ikeda, T; Maeda, T; Niwa, H; Okamoto, K | 1 |
Coban, AY; Durupinar, B; Ekinci, B | 1 |
Charavay, F; Merien, F; Perolat, P; Truccolo, J | 1 |
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
Furugo, I; Ishida, M; Takii, M; Ueda, M | 1 |
Chan, JK; Ma, J | 1 |
Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yamanaka, N; Yoshimori, K | 1 |
Kaldalu, N; Lewis, K; Mei, R | 1 |
Hiyama, L; Miller, LG; Tang, A | 1 |
Pistiolas, D; Robotis, J; Rokkas, T; Sechopoulos, P | 1 |
Asoh, N; Mizota, T; Nagatake, T; Oishi, K; Qin, L; Watanabe, H; Watanabe, K | 1 |
Ferraro, SM; Giacomelli, L; Marchese-Ragona, R; Marioni, G; Ottaviano, G; Rinaldi, R; Staffieri, A; Staffieri, C | 1 |
Di Conza, J; Massa, R; Méndez, E; Mollerach, A | 1 |
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP; Um, S; Yan, SB | 1 |
Fisher, A; Kahn, JB; Kaul, S; Khashab, M; Peterson, J | 1 |
Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
Audhya, A; Jain, S; Nagpure, PS | 1 |
Asakura, Y; Kobayashi, I | 1 |
Ito, A; Kawata, K; May, T; Okabe, S; Taniuchi, A | 1 |
Ejaz, M; Jabeen, K; Khan, E; Shezad, MF; Siddiqui, J; Zafar, A | 1 |
Tetz, GV; Tetz, VV | 1 |
An, J; Hao, XY; Li, ZS; Wang, GC; Zuo, GY | 1 |
Chen, X; Kallenbach, NR; Ren, D; Zhang, M; Zhou, C | 1 |
Bian, ZQ; Han, J; Li, Y; Wang, GC; Zhang, YL; Zuo, GY | 1 |
Abriouel, H; Benomar, N; Gálvez, A; Lavilla Lerma, L; Pérez Pulido, R; Sánchez Valenzuela, A | 1 |
Amato, SM; Brynildsen, MP; Orman, MA | 1 |
Aigner, D; Herzog, C; Lotter, C; Mayr, T; Nagl, S; Pfeiffer, SA; Poehler, E | 1 |
Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME | 1 |
Enrique Salcedo-Sora, J; Mc Auley, MT; Morgan, J; Smith, M | 1 |
Adeleye, AI; Ajayi, A; Akinpelu, S; Smith, SI | 1 |
Guo, Y; Ji, J; Ren, Y; Sun, J; Sun, X | 1 |
Clark, S; Clees, WI; Elkin, KR; Elliott, HA; Hayden, KR; Jones, M; Mashtare, ML; Preisendanz, HE; Read, AF; Richard, TL; Shreve, MJ; Silverman, J; Veith, TL; Watson, JE | 1 |
Balasubramanium, G; Elangovan, R; Gupta, SS; Lodha, T; Muthulakshmi, T; Perumal, V; Sivaraman, GK; Visnuvinayagam, S; Yadav, A | 1 |
2 review(s) available for ofloxacin and ampicillin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
5 trial(s) available for ofloxacin and ampicillin
Article | Year |
---|---|
AIDS patients with bacterial lower respiratory tract infections: treatment with ofloxacin versus sulbactam-ampicillin.
Topics: Adult; AIDS-Related Opportunistic Infections; Ampicillin; Bacterial Infections; Drug Therapy, Combination; Female; Humans; Male; Ofloxacin; Respiratory Tract Infections; Sulbactam | 1992 |
A clinical comparative study of ofloxacin and pivampicillin in acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Ampicillin; Bronchitis; Double-Blind Method; Female; Humans; Male; Ofloxacin; Pivampicillin; Sputum | 1988 |
Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acid; Clavulanic Acids; Diabetic Foot; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Male; Middle Aged; Ofloxacin; Penicillins; Prospective Studies; Sulbactam; Treatment Outcome | 1997 |
Short report: antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from patients with respiratory tract infections between 1987 and 2000, including beta-lactamase-negative ampicillin-resistant strains.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Ceftriaxone; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Japan; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Respiratory Tract Infections | 2007 |
Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pyelonephritis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2007 |
94 other study(ies) available for ofloxacin and ampicillin
Article | Year |
---|---|
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cadmium; Chelating Agents; Disk Diffusion Antimicrobial Tests; Ferrous Compounds; Ligands; Magnetic Resonance Spectroscopy; Metals, Heavy; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Organomercury Compounds; Organometallic Compounds; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Structure-Activity Relationship; Zinc | 2007 |
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
Topics: Anti-Infective Agents; Bacteria; Disk Diffusion Antimicrobial Tests; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Organometallic Compounds; Palladium; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spectrum Analysis, Raman; Yeasts | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
Topics: Anti-Infective Agents; Aza Compounds; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Ligands; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spectrum Analysis, Raman | 2009 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Mutation; Nucleotides; Ofloxacin | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae.
Topics: Acanthamoeba castellanii; Animals; Anti-Bacterial Agents; Chlamydiales; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Quinolones | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Apoptosis; Bacteria; Cattle; Cell Line, Tumor; DNA; Humans; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Yeasts | 2009 |
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cetylpyridinium; Disinfectants; Drug Resistance, Multiple, Bacterial; Membrane Proteins; Mutation; Norfloxacin; Quaternary Ammonium Compounds; Serratia marcescens | 2009 |
Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains.
Topics: Ampicillin; Anti-Bacterial Agents; Aza Compounds; Bacterial Proteins; Clindamycin; Clostridioides difficile; Cysteine Endopeptidases; DNA Gyrase; Fluoroquinolones; Frameshift Mutation; Immunoblotting; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Polymerase Chain Reaction; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Sequence Deletion | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
Topics: Acetylcysteine; Anti-Bacterial Agents; Culture Media; Drug Resistance, Bacterial; Expectorants; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 2010 |
A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities.
Topics: Animals; Anti-Infective Agents; Antiviral Agents; Bacteria; Cell Line; Chlorocebus aethiops; Drug Evaluation, Preclinical; Fungi; Herpesvirus 1, Human; Mannich Bases; Microbial Sensitivity Tests; Parainfluenza Virus 3, Human; Pyrones; Spectrum Analysis; Vero Cells | 2010 |
Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives.
Topics: Anti-Infective Agents; Antineoplastic Agents; Bacteria; Candida albicans; Catalytic Domain; Cell Line, Tumor; Chemistry Techniques, Synthetic; Humans; Molecular Docking Simulation; Pyrimidines; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Synthesis and biological evaluation of caracasine acid derivatives.
Topics: Amides; Anti-Bacterial Agents; Antineoplastic Agents; Antiprotozoal Agents; Bacillus cereus; Carboxylic Acids; Cell Line, Tumor; Cell Survival; Epoxy Compounds; Escherichia coli; Esters; Humans; Inhibitory Concentration 50; Leishmania mexicana; MCF-7 Cells; Phenanthrenes; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship; Trypanosoma cruzi | 2015 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Bis(N-amidinohydrazones) and N-(amidino)-N'-aryl-bishydrazones: New classes of antibacterial/antifungal agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Cell Line; Drug Discovery; Drug Resistance, Multiple; Fungi; Humans; Hydrazones; Microbial Sensitivity Tests; Mycoses | 2017 |
Synthesis and evaluation of 1,3,4-oxadiazole derivatives for development as broad-spectrum antibiotics.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Survival; Drug Design; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxadiazoles | 2019 |
Antibacterial effects of ofloxacin, clindamycin and sultamicillin on surgical removal of impacted third molars.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Clindamycin; Dental Care for Disabled; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Male; Molar, Third; Ofloxacin; Premedication; Sulbactam; Tooth Extraction; Tooth, Impacted | 1992 |
[The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Ciprofloxacin; Gentamicins; Humans; Ofloxacin; Pseudomonas aeruginosa | 1990 |
In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in mice.
Topics: Ampicillin; Animals; Chloramphenicol; Ciprofloxacin; Female; Liver; Mice; Microbial Sensitivity Tests; Ofloxacin; Salmonella Infections, Animal; Salmonella typhimurium; Spleen | 1990 |
[Susceptibilities of Escherichia coli, Salmonella and Staphylococcus aureus isolated from animals to ofloxacin and commonly used antimicrobial agents].
Topics: Ampicillin; Ampicillin Resistance; Animals; Cattle; Chickens; Chloramphenicol; Drug Resistance, Microbial; Escherichia coli; Kanamycin; Ofloxacin; Oxolinic Acid; Salmonella; Staphylococcus aureus; Swine | 1990 |
The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
Topics: Ampicillin; Ampicillin Resistance; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Penicillin Resistance | 1989 |
[In vitro antibiotic susceptibility of staphylococci].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Humans; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus; Sulbactam; Vancomycin | 1989 |
[Bone and suppurative lesion distribution of antimicrobial agents (ampicillin and ofloxacin) in experimental infected rabbits].
Topics: Ampicillin; Animals; Bacteroides Infections; Mandibular Diseases; Ofloxacin; Rabbits; Streptococcal Infections; Tissue Distribution | 1989 |
Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy.
Topics: Ampicillin; Animals; Azlocillin; Blood; Ciprofloxacin; Escherichia coli; Humans; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Sisomicin; Tobramycin | 1985 |
[Evaluation of in vivo activity of antibiotics against Chlamydia trachomatis in mice].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Chlamydia trachomatis; Chlamydiaceae Infections; Doxycycline; Female; Mice; Mice, Inbred Strains; Ofloxacin | 1988 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
[Bone penetration of antimicrobial agents (ABPC and OFLX) to rabbits].
Topics: Ampicillin; Animals; Bone and Bones; Ofloxacin; Rabbits | 1988 |
Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Clindamycin; Erythromycin; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Ofloxacin; Oxazines | 1987 |
The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Piperacillin | 1987 |
Influence of antibiotics on intestinal mucin in healthy subjects.
Topics: Administration, Oral; Adult; Ampicillin; Anti-Bacterial Agents; Bacitracin; Clindamycin; Doxycycline; Drug Combinations; Electrophoresis, Agar Gel; Erythromycin; Feces; Germ-Free Life; Humans; Intestinal Mucosa; Intestines; Metronidazole; Mucins; Nalidixic Acid; Ofloxacin; Oxazines; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Chloramphenicol; Enoxacin; Female; Haemophilus Infections; Haemophilus influenzae; Kinetics; Lung; Male; Mice; Naphthyridines; Ofloxacin; Oxazines; Pneumonia | 1987 |
[The antibacterial activity in vitro of ofloxacin in comparison with other orally administered antimicrobial substances on ampicillin-resistant clinical isolates].
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Humans; Ofloxacin; Oxazines; Penicillin Resistance | 1984 |
In vitro activity of eight antibiotics against Salmonella and Shigella species.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fleroxacin; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Salmonella; Shigella; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Assessment of the bactericidal activity of sparfloxacin, ofloxacin, levofloxacin, and other fluoroquinolones compared with selected agents of proven efficacy against Listeria monocytogenes.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Levofloxacin; Listeria monocytogenes; Listeriosis; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Comparison of the in vitro activity of levofloxacin and other antimicrobial agents against vancomycin-susceptible and vancomycin-resistant Enterococcus species.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Vancomycin | 1995 |
Treatment of experimental endocarditis due to ampicillin-susceptible or ampicillin-resistant Salmonella enteritidis.
Topics: Ampicillin; Ampicillin Resistance; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Endocarditis, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Salmonella enteritidis; Salmonella Infections | 1996 |
Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Penicillins; Rifampin; Sulbactam | 1996 |
Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice.
Topics: Ampicillin; Animals; Cefozopran; Ceftazidime; Cephalosporins; Cilastatin; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Imipenem; Mice; Mice, Inbred CBA; Ofloxacin; Pseudomonas Infections; Urinary Tract Infections | 1997 |
Assessment of the synergistic interactions of levofloxacin and ampicillin against Enterococcus faecium by the checkerboard agar dilution and time-kill methods.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents; beta-Lactam Resistance; Drug Therapy, Combination; Enterococcus faecium; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins | 1997 |
[Isolation rate of Enterococcus spp. from surgical infections and their susceptibilities].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Surgical Wound Infection; Thienamycins; Time Factors; Vancomycin | 1997 |
In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
Topics: Ampicillin; Anti-Infective Agents; Bacteria, Aerobic; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Sulbactam; Vancomycin | 1997 |
Sustained release of antibiotic from a fibrin-gelatin-antibiotic mixture.
Topics: Administration, Topical; Ampicillin; Anti-Bacterial Agents; Bacillus subtilis; Delayed-Action Preparations; Drug Combinations; Fibrin Tissue Adhesive; Gelatin Sponge, Absorbable; Gentamicins; Humans; In Vitro Techniques; Ofloxacin; Otitis Media | 1997 |
Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Nursing; Nursing Staff, Hospital; Ofloxacin; Oxacillin; Phylogeny; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1998 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Penicillins; Pneumococcal Infections | 1999 |
The bactericidal activity of levofloxacin against ampicillin-resistant and ampicillin-susceptible Haemophilus influenzae in comparison with ofloxacin, ciprofloxacin and sparfloxacin.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Haemophilus influenzae; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 1999 |
National guideline for the management of gonorrhoea in adults. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Contact Tracing; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Ofloxacin; Penicillins; Urethritis | 1999 |
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefaclor; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Levofloxacin; Methicillin; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillins | 1999 |
[Use of antibiotics in chronic bronchitis].
Topics: Administration, Oral; Adult; Ampicillin; Anti-Infective Agents; Bronchitis; Chronic Disease; Female; Humans; Male; Middle Aged; Ofloxacin; Penicillins; Treatment Outcome | 2000 |
Bacteremia and possible endocarditis caused by Moraxella phenylpyruvica.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Male; Moraxella; Neisseriaceae Infections; Ofloxacin; Penicillins | 2000 |
Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
Topics: Ampicillin; Anti-Infective Agents; Cefaclor; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Streptococcus pneumoniae | 2000 |
Antibiotic susceptibility, serum response and surface properties of Klebsiella species.
Topics: Ampicillin; Anti-Bacterial Agents; Cefuroxime; Gentamicins; Humans; Klebsiella; Microbial Sensitivity Tests; Ofloxacin; Sulbactam; Surface Properties; Xylenes | 2001 |
Antimicrobial susceptibilities of Campylobacter strains isolated from broilers in the southern part of Japan from 1995 to 1999.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cecum; Chickens; Drug Resistance, Microbial; Erythromycin; Japan; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Penicillins; Poultry Diseases; Tetracycline | 2001 |
In vitro effects of ampicillin, ciprofloxacin and ofloxacin on Salmonella typhi within human monocyte-derived macrophages.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Humans; Macrophages; Microbial Sensitivity Tests; Monocytes; Ofloxacin; Penicillins; Salmonella typhi | 2001 |
Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cricetinae; Doxycycline; Leptospira; Leptospirosis; Mesocricetus; Ofloxacin; Penicillins; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases | 2002 |
[Microbiological and clinical studies of Haemophilus influenzae isolated at Kitakyushu Municipal Medical Center from 1996 through 1999].
Topics: Adult; Aged; Ampicillin; Anti-Infective Agents; beta-Lactamases; Cefaclor; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Respiratory System; Seasons; Sulbactam; Thienamycins | 2002 |
Granulomatous osteomyelitis caused by bacteria other than mycobacteria: a report of two cases.
Topics: Adult; Ampicillin; Anti-Infective Agents; Ciprofloxacin; Female; Granuloma; Humans; Male; Middle Aged; Ofloxacin; Osteomyelitis; Penicillins; Salmonella; Salmonella Infections; Serratia Infections; Serratia marcescens; Treatment Outcome | 2002 |
[Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs].
Topics: Acute Disease; Ampicillin; Anti-Infective Agents; Azithromycin; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Clarithromycin; Enterobacteriaceae; Haemophilus influenzae; Humans; Levofloxacin; Ofloxacin; Penicillin G; Pharyngitis; Streptococcus pneumoniae; Streptococcus pyogenes; Tonsillitis | 2003 |
Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Escherichia coli; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Ofloxacin; Oligonucleotide Array Sequence Analysis; Penicillins; Phosphates; Polysaccharides; Regulon; RNA, Bacterial; Transcription, Genetic | 2004 |
Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Biological Availability; Drug Therapy, Combination; Female; Humans; Levofloxacin; Ofloxacin; Polycystic Kidney, Autosomal Dominant; Pyelonephritis; Streptococcal Infections; Streptococcus agalactiae | 2006 |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
Topics: Amoxicillin; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Omeprazole; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
Burkholderia cepacia complex nasal isolation in immunocompetent patients with sinonasal polyposis not associated with cystic fibrosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cefazolin; Ceftibuten; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nasal Polyps; Ofloxacin; Prospective Studies; Sinusitis; Sulbactam | 2007 |
[Streptococcus agalactiae isolated in Santa Fe, Argentina: antibiotic susceptibility and erythromycin-clindamycin resistance mechanisms].
Topics: Ampicillin; Argentina; Bacterial Proteins; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Humans; Methyltransferases; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Polymerase Chain Reaction; Streptococcal Infections; Streptococcus agalactiae | 2007 |
Effect of recombinant human activated protein C on the bactericidal activity of human monocytes and modulation of pro-inflammatory cytokines in the presence of antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Blood Bactericidal Activity; Cytokines; Escherichia coli; Humans; In Vitro Techniques; Inflammation; Interleukin-1beta; Interleukin-8; Kinetics; Levofloxacin; Monocytes; Ofloxacin; Protein C; Recombinant Proteins; Tumor Necrosis Factor-alpha | 2007 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Aural myiasis in a 1-day-old neonate.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Diptera; Drug Therapy, Combination; Ear Canal; Ear Diseases; Female; Humans; Infant, Newborn; Myiasis; Ofloxacin | 2008 |
From damaged genome to cell surface: transcriptome changes during bacterial cell death triggered by loss of a restriction-modification gene complex.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Death; DNA Damage; DNA Restriction-Modification Enzymes; Escherichia coli; Escherichia coli Proteins; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genome, Bacterial; Kinetics; Ofloxacin; Regulon; SOS Response, Genetics | 2009 |
Increased antibiotic resistance of Escherichia coli in mature biofilms.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Drug Resistance, Bacterial; Escherichia coli; Gene Expression Profiling; Kanamycin; Microbial Viability; Ofloxacin | 2009 |
Trends in antimicrobial resistance in Shigella species in Karachi, Pakistan.
Topics: Adolescent; Adult; Age Factors; Ampicillin; Anti-Infective Agents; Ceftriaxone; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Dysentery, Bacillary; Humans; Infant; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Pakistan; Shigella; Trimethoprim, Sulfamethoxazole Drug Combination | 2009 |
Effect of extracellular DNA destruction by DNase I on characteristics of forming biofilms.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Biomass; Deoxyribonuclease I; DNA; Escherichia coli; Microbial Viability; Ofloxacin; Staphylococcus aureus | 2010 |
Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Ceftazidime; Drug Synergism; Flavonols; Glycosides; Humans; Hypericum; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ofloxacin; Quercetin; Sputum | 2011 |
Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biofilms; Cell Membrane; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Ofloxacin; Oligopeptides; Plankton | 2011 |
Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Berberine; Cefazolin; Drug Combinations; Drug Interactions; Drug Resistance, Multiple, Bacterial; Drug Synergism; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ofloxacin | 2012 |
Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
Topics: Ampicillin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Fermentation; Food Contamination; Food Microbiology; Genes, Bacterial; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Penicillins; Phenotype; Vancomycin | 2013 |
Metabolic control of persister formation in Escherichia coli.
Topics: Adaptation, Physiological; Ampicillin; Anti-Bacterial Agents; Antitoxins; Bacterial Load; Bacterial Toxins; Carbon; Cyclic AMP; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Glucose; Guanosine Tetraphosphate; Microbial Viability; Ofloxacin; Pyrophosphatases; Signal Transduction; Time Factors | 2013 |
Label-free microfluidic free-flow isoelectric focusing, pH gradient sensing and near real-time isoelectric point determination of biomolecules and blood plasma fractions.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Blood Proteins; Electrophoresis, Microchip; Equipment Design; Humans; Hydrogen-Ion Concentration; Isoelectric Focusing; Isoelectric Point; Lactalbumin; Lactoglobulins; Ofloxacin | 2015 |
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment | 2018 |
Disrupting folate metabolism reduces the capacity of bacteria in exponential growth to develop persisters to antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Folic Acid; Ofloxacin | 2018 |
Efflux pump activity, biofilm formation and antibiotic resistance profile of Klebsiella spp. isolated from clinical samples at Lagos University Teaching Hospital.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Biofilms; Cefuroxime; Cells, Cultured; Community-Acquired Infections; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitals, Teaching; Hospitals, University; Humans; Imipenem; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Nigeria; Ofloxacin; Tertiary Care Centers | 2020 |
A novel concentration gradient microfluidic chip for high-throughput antibiotic susceptibility testing of bacteria.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Equipment Design; High-Throughput Screening Assays; Humans; Microbial Sensitivity Tests; Microfluidic Analytical Techniques; Ofloxacin; Salmonella; Salmonella Infections | 2021 |
Impacts of the COVID-19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania.
Topics: Acetaminophen; Ampicillin; Animals; Anti-Bacterial Agents; COVID-19; Dexamethasone; Doxycycline; Environmental Monitoring; Humans; Hydroxychloroquine; Naproxen; Ofloxacin; Pandemics; Pennsylvania; Pharmaceutical Preparations; Soil; Sulfamethoxazole; Trimethoprim; Waste Disposal, Fluid; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2022 |
Prevalence of S. aureus and/or MRSA from seafood products from Indian seafood products.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Gentamicins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Ofloxacin; Piperacillin; Prevalence; Rifampin; Seafood; Serine; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination; Virulence Factors | 2022 |